🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
The rationale for this trial is to demonstrate the feasibility and safety o...
Status
Completed
Location
Mayo Clinic - Phoenix
Start Date
2011-09
Trial ID
NCT01410344
The primary objective is to cure multiple myeloma with less toxic allogenei...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-08
Trial ID
NCT00854139
This randomized phase II trial studies how well treosulfan and fludarabine ...
Status
Unknown
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2013-11
Trial ID
NCT01894477
To find out if it is possible for HIV-1 patients to maintain antiretroviral...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center
Start Date
2013-06
Trial ID
NCT01836068
Treatments Being Tested
This is a clinical trial of bone marrow transplantation for patients with t...
Status
Completed
Location
Children Hospital Los Angeles
Start Date
2008-08
Trial ID
NCT00730314
Treatments Being Tested
A Phase 1/2 study to evaluate the safety, tolerability, and efficacy of an ...
Status
Terminated
Location
UCLA Mattel Children's Hospital
Start Date
2017-03-20
Trial ID
NCT02963064
Treatments Being Tested
The study is a Phase II clinical trial. Patients will receive intensity mod...
Status
Recruiting
Location
University of Illinois at Chicago
Start Date
2017-03-20
Trial ID
NCT03121001
Our primary objective is to determine if it is feasible for SAA patients to...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center
Start Date
2014-08
Trial ID
NCT02224872